Sex Hormones Market Projected to Gain Significant Value by 2023

The global Sex Hormones Market is thoroughly analysed by covering major segments of the market. An in-depth market segmentation is covered below that reflects the vital elements included in the wearable gaming accessories market research report. According to market is projected to grow at a stellar CAGR during the period of assessment, 2019-2023.

Global Sex Hormones Market overview:

The report of global Sex Hormones Market includes the competitive landscape section which provides the full and in-depth analysis of the current market trends, changing technologies and developments that will be beneficial for the companies, which are competing in the market. The report offers an overview of revenue, demand, and supply of data, futuristic cost, and growth analysis during the projected the year.

Available Exclusive Sample Copy of this Report @

The growing demand for Sex Hormones has provided a major boost to the Global Sex Hormones Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2019 up to 2023.

Sexual motivation is influenced by Hormones such as Testosterone, Estrogen, Progesterone, Oxytocin, and Vasopressin. In most mammalian species, Sex Hormones control the ability to engage in sexual behaviors. However, sex hormones do not directly regulate the ability to copulate in primates (including humans).

The global Sex Hormones Market is primarily segmented based on Product Type, Application, End Use Industry and Regions.

Based on Product Type, the market is divided into:

  • Progesterone
  • Testosterone
  • Drospirenone

On the basis of End Use Industry, the market is split into:

  • Topical
  • Inhalation
  • Injection
  • Oral

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Some of the major players that operate in the Global Sex Hormones Market are Pfizer, Novartis, Merck, Sanofi, Bayer, GSK, AstraZeneca, Cipla, Zizhu Pharma.

Latest Industry Updates:

Pfizer – Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, and Pfizer, Inc. (NYSE: PFE) today announced updated results from the Phase 1/2 Alta study evaluating investigational SB-525 gene therapy for severe hemophilia A. The data showed that SB-525 was generally well-tolerated and demonstrated a dose-dependent increase in Factor VIII (FVIII) activity levels. The first two patients treated at the 3e13 vg/kg dose rapidly achieved normal levels of FVIII activity as measured using a chromogenic assay, with no reported bleeding events, and the response continues to be durable for as long as 24 weeks, the extent of follow-up.

The two patients more recently treated at the 3e13 vg/kg dose level are demonstrating FVIII activity kinetics that appear consistent with the first two patients treated in this dose cohort at similar early time points. Data from 10 patients treated with SB-525 were presented during an oral presentation on July 6 at the XXVII Congress of the International Society on Thrombosis and Haemostasis (ISTH), in Melbourne, Australia. The SB-525 ISTH presentation slides, which include the full data set, are available on Sangamo’s website in the Investors and Media section under Events and Presentations.

“The initial results with SB-525 gene therapy for patients with severe hemophilia A continue to look very promising,” said Barbara Konkle, M.D., Bloodworks Northwest, Professor of Medicine at University of Washington and a Principal Investigator of the Alta study. “It is encouraging that patients in the 3e13 vg/kg cohort have attained normal Factor VIII levels within 5-7 weeks of treatment with SB-525 gene therapy and have sustained Factor VIII activity with no bleeding episodes. It will be important to continue to follow these patients to understand the potential long-term durability of this gene therapy.”

 Market segment by Regions/Countries, this report covers:

1 North America Country (United States, Canada)

2 South America

3 Asia Country (China, Japan, India, Korea)

4 Europe Country (Germany, UK, France, Italy)

5 Other Country (Middle East, Africa, GCC)

Grab Your Report at an Impressive Discount @ . 

Table of Contents:

Global Sex Hormones Market Report 2019

Section 1 Sex Hormones Product Definition

Section 2 Global Sex Hormones Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Sex Hormones Shipments

2.2 Global Manufacturer Sex Hormones Business Revenue

2.3 Global Sex Hormones Market Overview

Section 3 Manufacturer Sex Hormones Business Introduction

3.1 Pfizer Sex Hormones Business Introduction

3.1.1 Pfizer Sex Hormones Shipments, Price, Revenue and Gross profit 2014-2018

3.1.2 Pfizer Sex Hormones Business Distribution by Region

3.1.3 Pfizer Interview Record

3.1.4 Pfizer Sex Hormones Business Profile

3.1.5 Pfizer Sex Hormones Product Specification

………………. Request free sample to get a complete Table of Content

About us is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India



Publication author

offline 6 hours


Comments: 0Publics: 346Registration: 26-06-2019
Войти с помощью: 
Войти с помощью: 
Password generation